ANGARUS THERAPEUTICS
Angarus Therapeutics develops immuno-oncology therapies intended to respond to the urgent needs of cancer treatment. The therapy serves as checkpoint blockers on the innate immunity STING pathway, with preclinical data demonstrating that a combination of checkpoint blockers, both innate and adaptive, leads to long term survival, enabling patients with a wide range of cancer treatments. Chih-Ping Liu established the company in Sunnyvale, California in 2018.
ANGARUS THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2018-01-01
Address:
Sunnyvale, California, United States
Country:
United States
Website Url:
http://www.angarustherapeutics.com
Total Employee:
51+
Status:
Active
Contact:
650-575-1702
Total Funding:
11.32 M USD
Technology used in webpage:
Euro GoDaddy DNS Squarespace Hosted
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Nanocan Therapeutics
Nanocan Therapeutics provides medicines and other products intended to patients with certain cancers, respiratory tract infections.
Current Employees Featured
Founder
Investors List
Foothill Ventures
Foothill Ventures investment in Venture Round - Angarus Therapeutics
Official Site Inspections
http://www.angarustherapeutics.com
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
